153 related articles for article (PubMed ID: 37211351)
21. Effect of pre-treatment with gonadotropin-releasing hormone analogue GnRH-α on high-intensity focussed ultrasound ablation for diffuse adenomyosis: a preliminary study.
Xiao-Ying Z; Ying-Shu G; Jiu-Mei C; Jin-Juan W; Hong Y; Chun-Yi Z; Hua D
Int J Hyperthermia; 2018 Dec; 34(8):1289-1297. PubMed ID: 29447020
[TBL] [Abstract][Full Text] [Related]
22. Effects of oxytocin on high intensity focused ultrasound (HIFU) ablation of adenomysis: a prospective study.
Zhang X; Zou M; Zhang C; He J; Mao S; Wu Q; He M; Wang J; Zhang R; Zhang L
Eur J Radiol; 2014 Sep; 83(9):1607-11. PubMed ID: 24951357
[TBL] [Abstract][Full Text] [Related]
23. [Feasibility and safety of MRgFUS ablation for uterine fibroids and adenomyosis: a preliminary study].
Huang YQ; Zhou SG; Wang J; Deng LX; Li ZW; Xu YH
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1152-1155. PubMed ID: 31006218
[No Abstract] [Full Text] [Related]
24. Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: A retrospective study.
Xiong Y; Yue Y; Shui L; Orsi F; He J; Zhang L
Int J Hyperthermia; 2015; 31(7):777-83. PubMed ID: 26367457
[TBL] [Abstract][Full Text] [Related]
25. High intensity focused ultrasound treatment for adenomyosis: comparison of efficacy based on MRI features.
Zhao Y; Luo S; Liu Y; He Y; Liu X; Guohua H; He J
Int J Hyperthermia; 2023; 40(1):2197574. PubMed ID: 37031960
[TBL] [Abstract][Full Text] [Related]
26. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: A review of 9988 cases.
Chen J; Chen W; Zhang L; Li K; Peng S; He M; Hu L
Ultrason Sonochem; 2015 Nov; 27():671-676. PubMed ID: 26093678
[TBL] [Abstract][Full Text] [Related]
27. High intensity focused ultrasound for the treatment of adenomyosis: selection criteria, efficacy, safety and fertility.
Zhang L; Rao F; Setzen R
Acta Obstet Gynecol Scand; 2017 Jun; 96(6):707-714. PubMed ID: 28437003
[TBL] [Abstract][Full Text] [Related]
28. Long-term re-intervention after USgHIFU and prediction of NPVR in different ages of patients with uterine fibroids.
Li S; Ma WW; Yang MJ; Deng YB; Hu L; Chen JY
Int J Hyperthermia; 2024; 41(1):2304264. PubMed ID: 38258583
[TBL] [Abstract][Full Text] [Related]
29. High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results.
Shui L; Mao S; Wu Q; Huang G; Wang J; Zhang R; Li K; He J; Zhang L
Ultrason Sonochem; 2015 Nov; 27():677-681. PubMed ID: 26050604
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound-guided high intensity focused ultrasound for the treatment of gynaecological diseases: A review of safety and efficacy.
Zhang L; Zhang W; Orsi F; Chen W; Wang Z
Int J Hyperthermia; 2015 May; 31(3):280-4. PubMed ID: 25609456
[TBL] [Abstract][Full Text] [Related]
31. Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis: A Retrospective Study.
Liu X; Wang W; Wang Y; Wang Y; Li Q; Tang J
Medicine (Baltimore); 2016 Jan; 95(3):e2443. PubMed ID: 26817877
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of physician experience in achieving non-perfused volume ratio of high-intensity focused ultrasound ablation for uterine fibroids: a multicentre study.
Gong X; Zhang X; Liu D; Yang C; Zhang R; Xiao Z; Chen W; Chen J
J Int Med Res; 2022 May; 50(5):3000605221102087. PubMed ID: 35634930
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging T2WI hyperintense foci number and the prognosis of adenomyosis after high-intensity focused ultrasound treatment.
Du CC; Wang YQ; Qu DC; Jiang LP; Yu X; Zhou HG
Int J Gynaecol Obstet; 2021 Aug; 154(2):241-247. PubMed ID: 33421123
[TBL] [Abstract][Full Text] [Related]
34. [Pregnancy outcomes and symptom improvement of patients with adenomyosis treated with high intensity focused ultrasound ablation].
Zhou CY; Xu XJ; He J
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):845-849. PubMed ID: 27916069
[No Abstract] [Full Text] [Related]
35. Ultrasound-guided HIFU for uterine fibroids of hyperintense on T2-weighted MR imaging with or without GnRH-analogue-pretreated: A propensity score matched cohort study.
Jiang L; Yu JW; Yang MJ; Zhong Q; Chen JY
Front Surg; 2022; 9():975839. PubMed ID: 35990089
[TBL] [Abstract][Full Text] [Related]
36. Comparison of high-intensity focused ultrasound for the treatment of internal and external adenomyosis based on magnetic resonance imaging classification.
Xu F; Lin Z; Wang Y; Gong C; He M; Guo Q; Wang Z; Lian Z
Int J Hyperthermia; 2023; 40(1):2211268. PubMed ID: 37202156
[TBL] [Abstract][Full Text] [Related]
37. Efficacy, Efficiency, and Safety of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Ablation of Uterine Fibroids: Comparison with Ultrasound-Guided Method.
Wang Y; Wang ZB; Xu YH
Korean J Radiol; 2018; 19(4):724-732. PubMed ID: 29962878
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a radiomics model based on T2-weighted imaging for predicting the efficacy of high intensity focused ultrasound ablation in uterine fibroids.
Cheng Y; Yang L; Wang Y; Kuang L; Pan X; Chen L; Cao X; Xu Y
Quant Imaging Med Surg; 2024 Feb; 14(2):1803-1819. PubMed ID: 38415139
[TBL] [Abstract][Full Text] [Related]
39. Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound.
Zhang X; Li K; Xie B; He M; He J; Zhang L
Int J Gynaecol Obstet; 2014 Mar; 124(3):207-11. PubMed ID: 24380611
[TBL] [Abstract][Full Text] [Related]
40. Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids-short-term and long-term results.
Lee JY; Chung HH; Kang SY; Park EJ; Park DH; Son K; Han JK
Eur Radiol; 2020 Mar; 30(3):1554-1563. PubMed ID: 31705252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
